At a glance
- Originator Eisai Co Ltd
- Class Analgesics; Neuroprotectants; Nootropics
- Mechanism of Action Acetylcholinesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease
Most Recent Events
- 02 Oct 2000 Discontinued-Preclinical for Alzheimer's disease in Japan (Unknown route)